These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 4354559

  • 1. Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues.
    Sheppard H, Wiggan G, Tsien WH.
    Adv Cyclic Nucleotide Res; 1972; 1():103-12. PubMed ID: 4354559
    [No Abstract] [Full Text] [Related]

  • 2. Age-related changes in vascular responsiveness to cyclic nucleotides and contractile agonists.
    Cohen ML, Berkowitz BA.
    J Pharmacol Exp Ther; 1974 Oct; 191(1):147-55. PubMed ID: 4371517
    [No Abstract] [Full Text] [Related]

  • 3. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. II. Effects of papaverine.
    Cubeddu L, Barnes E, Weiner N.
    J Pharmacol Exp Ther; 1974 Dec; 191(3):444-57. PubMed ID: 4372339
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitors of cyclic-nucleotide phosphodiesterase induce morphological differentiation of mouse neuroblastoma cell culture.
    Prasad KN, Sheppard JR.
    Exp Cell Res; 1972 Aug; 73(2):436-40. PubMed ID: 4341007
    [No Abstract] [Full Text] [Related]

  • 5. Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle relaxation.
    Lugnier C, Bertrand Y, Stoclet JC.
    Eur J Pharmacol; 1972 Jul; 19(1):134-6. PubMed ID: 4340226
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M, Harris DN.
    Adv Cyclic Nucleotide Res; 1976 Jul; 7():225-64. PubMed ID: 188316
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Study of phosphodiesterase inhibitors on lipolysis, phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in isolated fat cells.
    Allen DO, Clark JF, Ashmore J.
    J Pharmacol Exp Ther; 1973 May; 185(2):379-85. PubMed ID: 4350040
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of phosphodiesterase activity in brain cortical slices from guinea pig and rat.
    Schultz J.
    Pharmacol Res Commun; 1974 Aug; 6(4):335-41. PubMed ID: 4373768
    [No Abstract] [Full Text] [Related]

  • 12. Cyclic nucleotide phosphodiesterases.
    Appleman MM, Thompson WJ, Russell TR.
    Adv Cyclic Nucleotide Res; 1973 Aug; 3():65-98. PubMed ID: 4361529
    [No Abstract] [Full Text] [Related]

  • 13. Phosphodiesterase activity of the lower urinary tract.
    Levin RM, Einstein R, Wein AJ.
    J Urol; 1982 Sep; 128(3):615-7. PubMed ID: 6288975
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of 3',5'-nucleotide phosphodiesterase in guinea pig cerebral cortical slices.
    Schultz J.
    Arch Biochem Biophys; 1974 Jul; 163(1):15-20. PubMed ID: 4368825
    [No Abstract] [Full Text] [Related]

  • 16. Effects of catecholamines, cyclic nucleotides and phosphodiesterase inhibitors on contractions of skeletal muscles in anaesthetized cats.
    Bowman WC, Nott MW.
    Clin Exp Pharmacol Physiol; 1974 Jul; 1(4):309-23. PubMed ID: 4376475
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.